Truist Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
Truist Financial's MDGL Position: Q3 2026 in Review
Truist Financial reduced its Madrigal Pharmaceuticals (MDGL) stake by 7.1% in Q3 2026, selling an estimated $20.1K and leaving 496 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #2619.
Truist Financial first reported a position in MDGL in Q2 2024 and has held it in 6 quarters since. The position peaked at $331K in Q4 2025. 332 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Truist Financial held 496 shares of Madrigal Pharmaceuticals worth $250K as of Q3 2026.
- Truist Financial sold 38 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $20.1K.
- Madrigal Pharmaceuticals made up ﹤0.01% of Truist Financial's portfolio in Q3 2026, its #2619 holding.
- Truist Financial first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
- Truist Financial's Madrigal Pharmaceuticals position peaked at $331K in Q4 2025.
- 332 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Truist Financial's 13F filing for Q3 2026, filed 30 Oct 2026.